by Team Small News | Oct 30, 2025 | Pharma, Zydus
Zydus Lifesciences, a pharmaceutical company, has been instructed to revise a post-marketing surveillance (PMS) study for its Tofacitinib ER (extended-release) tablets. The company had submitted the study protocol to the regulatory authorities, but it appears that the...